Wasatch Advisors’s Transmedics TMDX Stock Holding History

Wasatch Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27.8M	Buy	333,162 +24,728	+8%	+$2.03M	0.21%	104
2026 Q2	$20.5M	Sell	308,434 -37,710	-11%	-$3.19M	0.13%	117
2026 Q1	$34.4M	Buy	346,144 +14,296	+4%	+$1.86M	0.23%	93
2025 Q4	$40.4M	Buy	331,848 +6,646	+2%	+$834K	0.24%	93
2025 Q3	$36.5M	Sell	325,202 -10,124	-3%	-$1.19M	0.2%	107
2025 Q2	$44.9M	Sell	335,326 -117,959	-26%	-$13M	0.24%	95
2025 Q1	$30.5M	Buy	453,285 +11,931	+3%	+$821K	0.17%	107
2024 Q4	$27.5M	Buy	441,354 +200,603	+83%	+$18.7M	0.14%	120
2024 Q3	$37.8M	Sell	240,751 -53,976	-18%	-$8.32M	0.19%	107
2024 Q2	$44.4M	Sell	294,727 -140,244	-32%	-$16.8M	0.24%	95
2024 Q1	$32.2M	Buy	+434,971	New	+$35.9M	0.17%	113
2019 Q4	–	Sell	-23,363	Closed	-$555K	–	255
2019 Q3	$555K	Sell	23,363 -26,928	-54%	-$646K	0.01%	236
2019 Q2	$1.46M	Buy	+50,291	New	+$1.37M	0.01%	226

Other funds holding TMDX

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

Taylor Frigon Capital Management Scottsdale, Arizona $197M AUM 35.01% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Wasatch Advisors's TMDX Position: Q3 2026 in Review

Wasatch Advisors increased its Transmedics (TMDX) stake by 8% in Q3 2026, buying an estimated $2.03M and bringing the position to 333,162 shares worth $27.8M. The position accounts for 0.21% of the portfolio, ranked #104.

Wasatch Advisors first reported a position in TMDX in Q2 2019 and has held it in 13 quarters since. The position peaked at $44.9M in Q2 2025. 107 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

Wasatch Advisors held 333,162 shares of Transmedics worth $27.8M as of Q3 2026.
Wasatch Advisors bought 24,728 Transmedics shares in Q3 2026, an estimated $2.03M.
Transmedics made up 0.21% of Wasatch Advisors's portfolio in Q3 2026, its #104 holding.
Wasatch Advisors first reported a position in Transmedics in Q2 2019 and has held it in 13 quarters since.
Wasatch Advisors's Transmedics position peaked at $44.9M in Q2 2025.
107 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Wasatch Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.